Showing 41 - 60 results of 260 for search '(( significantly impacter decrease ) OR ( significantly impair decrease ))~', query time: 0.42s Refine Results
  1. 41
  2. 42
  3. 43
  4. 44
  5. 45
  6. 46

    Fig 2 - by Masoud Rahmati (16665456)

    Published 2025
    Subjects:
  7. 47
  8. 48
  9. 49
  10. 50

    The impact of refractive error correction on health-related quality of life in nursing home residents in Armenia by Aida Giloyan (16826909)

    Published 2025
    “…About 42.0% had mild to severe visual impairment (VI), while 5.0% were blind. At the follow-up, the normal vision improved from 52.8% to 64.9%, while mild to severe VI decreased from 42.3% to 30.3%. …”
  11. 51
  12. 52

    Characteristics of JIA patients. by Yasmine Makhlouf (17409866)

    Published 2025
    “…Before biologic treatment, 15% of patients exhibited growth delay, while 75.4% had impaired growth. Following biologic therapy, growth delay decreased to 8% and impaired growth to 36.8%. …”
  13. 53

    List of excluded articles. by Yasmine Makhlouf (17409866)

    Published 2025
    “…Before biologic treatment, 15% of patients exhibited growth delay, while 75.4% had impaired growth. Following biologic therapy, growth delay decreased to 8% and impaired growth to 36.8%. …”
  14. 54
  15. 55
  16. 56

    Presentation 1_Telehealth coaching in older adults, behavior change, and impacts of the COVID-19 pandemic: analyses from The Brain Health Champion Study.pdf by Brittany McFeeley (21104825)

    Published 2025
    “…</p>Discussion<p>Our findings suggest that pandemic restrictions significantly impacted activities typically done outside the home (social and physical activity), while those feasibly achieved at home were less affected (Mediterranean diet adherence and cognitive activity). …”
  17. 57
  18. 58

    Metabolic characteristics of T2DM mice. by Yan Zhu (112437)

    Published 2025
    “…<div><p>Background</p><p>Type 2 diabetes mellitus (T2DM) is associated with cognitive dysfunction, which significantly impacts the quality of life. Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has shown potential neuroprotective effects. …”
  19. 59

    Schematic diagram of the study design. by Yan Zhu (112437)

    Published 2025
    “…<div><p>Background</p><p>Type 2 diabetes mellitus (T2DM) is associated with cognitive dysfunction, which significantly impacts the quality of life. Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has shown potential neuroprotective effects. …”
  20. 60

    Image 2_PLK1 inhibition impairs erythroid differentiation.jpeg by Peijun Jia (11334594)

    Published 2024
    “…More specifically, PLK1 inhibition impaired the differentiation and erythroid commitment of hematopoietic stem cells in the bone marrow, resulting in abnormal accumulation of BFU-E cells and reduced proliferation and differentiation of CFU-E, and a decrease in the number of terminal erythrocytes. …”